USPTO serial 76249401
MERADIV
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DEFORD, JEFFREY S
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MERADIV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boehringer Ingelheim Pharma KG
55216 Ingelheim am Rhein, DE
Boehringer Ingelheim Pharma KG
55216 Ingelheim am Rhein, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin J. Beran
MARTIN J BERAN OSTROLENK, FABER, GERB & SOFFEN, LLP1180 AVE OF THE AMERICASNEW YORK, NY 10036-8403UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases or disorders of the cardiovascular system, the central nervous system, the musculoskeletal system, respiratory organs and the immunological system, for the treatment of cancer and AIDS, all for human use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 10, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 10, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 26, 2005 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 23, 2005 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 23, 2005 | PAPER RECEIVED | — | |
| Oct 28, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 28, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 28, 2004 | PAPER RECEIVED | — | |
| Aug 16, 2004 | CFIT | CASE FILE IN TICRS | — |
| Mar 19, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 8, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 8, 2004 | PAPER RECEIVED | — | |
| Oct 29, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 29, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 29, 2003 | PAPER RECEIVED | — | |
| May 6, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 17, 2002 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 11, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 11, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 26, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2001 | DOCK | ASSIGNED TO EXAMINER | — |